Companies: 10,795·Total market cap: $144.5T
Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL.VTSXVHealthcare● Active
$0.20
+$0.00(+2.56%)
Market Cap$12290517
P/E Ratio—
52W High$0.4
52W Low$0.09
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Marvel Biosciences Corp.（MRVL.V）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MRVL.V · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.04mrvl.v eps ttm · mrvl.v earnings per shareEarnings history
PE Ratio (TTM)—mrvl.v pe ratio ttm · mrvl.v price to earningsPE Ratio deep dive
Revenue (TTM)0.00mrvl.v revenue ttm · mrvl.v annual revenueFull revenue history
Dividend Yield不分红does mrvl.v pay dividends · mrvl.v dividend yieldDividend history
Shares Outstanding47.3Mmrvl.v shares outstanding · mrvl.v floatShares outstanding history
Next EarningsJun 17, 2026Est.mrvl.v earnings date · mrvl.v next earningsEarnings history

探索 Marvel Biosciences Corp. 数据

mrvl.v stock data · financials
市值$12.3Mmrvl.v market cap · mrvl.v valuation
分析师预测—
股息不分红does marvel biosciences corp. pay dividends · mrvl.v dividend yield
营收—marvel biosciences corp. annual revenue · mrvl.v revenue
盈利EPS $-0.05+99.89%mrvl.v earnings · mrvl.v eps
市盈率—mrvl.v pe ratio · mrvl.v price to earnings

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
marvel biosciences corp. revenue · mrvl.v revenue 2025
FY 2025Net Income-$2.2M▼ 133928.36% YoY
202320242025
marvel biosciences corp. net income · mrvl.v profit 2025
FY 2025EPS$-0.05▲ +99.89% YoY
202320242025
mrvl.v eps · marvel biosciences corp. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$2.1MEPS: $-0.04View income statement →

股票表现

完整历史
1D+23.08%
1W+45.45%
1M+60.00%
3M+71.43%
YTD+77.78%
1Y+140.00%
5Y-38.46%

关于 Marvel Biosciences Corp.

CEOJ. Roderick Matheson
IPO DateJul 13, 2021
Employees5
CountryCA
Websitemarvelbiotechnology.com

Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs…

BiotechnologyHealthcareTSXVCA

what is marvel biosciences corp. · mrvl.v stock overview · marvel biosciences corp. company profile · who is marvel biosciences corp. ceo · mrvl.v TSXV · marvel biosciences corp. headquarters · marvel biosciences corp. business segments

关于股票概览与关键数据

Marvel Biosciences Corp.（MRVL.V）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 13, 2021 在 TSXV 上市。截至最近交易日，MRVL.V 股价为 $0.20，市值约为 $12.3M。过去12个月累计回报 +140.00%，年初至今回报 +77.78%。

2025 财年 Marvel Biosciences Corp. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Marvel Biosciences Corp.（MRVL.V）股价为 $0.20，在 TSXV 上市，52周区间为 $0.09 – $0.40。

MRVL.V 最新股价MRVL.V quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议